Vaccines Preparation: Development and Administration Routes

Vaccines are immunological preparations administered to improve immunity to a particular illness. Once in the body, the immunization agents stimulate an immune reaction to a particular antigen from a disease-causing pathogen to initiate healing. As such, it is paramount to understand the principles of vaccination preparation, new vaccine development, administration routes, and adverse effects to address people’s concerns about vaccines. Vaccine preparation and development must follow compulsory, which should be completed before health practitioners administer them to human subjects to avoid detrimental implications and controversies.

Vaccines Preparation Process

Vaccination preparation involves mandatory steps manufacturers must follow to produce quality and effective vaccines. The initial step involves generating an antigen from the microbe grown based on the vaccination type to satisfy optimal requirements. During the process, scientists grow a microbe or virus on primary cells, including chicken eggs for influenza or cultured human cells for Hepatitis A vaccination. Furthermore, vaccine manufacturers may use toxins or toxoids from organisms or part of the microorganism when making vaccines for Diphtheria or tetanus. Finally, chemicals or heat weakens bacteria viruses when making polio vaccines (Mandal, 2023). Thus, based on the vaccines under production, the preparation process requires different approaches to generate the antigen.

The second step entails separating an antigen from its host cell. If generated from an attenuated virus, an antigen does not require purification but must be decontaminated if made from recombinant proteins. Besides, sometimes recombinant proteins may require multiple operations, including ultrafiltration and column chromatography for decontamination before administration. In the third step, adjuvants, stabilizers, and preservatives are added to the developed antigen for formulation. An adjuvant enhances its immune response, stabilizers increase storage life, and preservatives allow multi-dose bottles. However, developing and producing combination vaccines is difficult because inconsistencies and interactions among antigens and other vaccine ingredients may arise. Still, regardless of the process, products need protection from air, water, and human contaminants, and ensure the antigens do not spill into the surroundings for the process to be effective (Mandal, 2023). The vaccine preparation process must follow appropriate steps and protect antigens and the surroundings from contamination.

Vaccines Development Process

Vaccine development involves three major phases: exploratory; preclinical; and post-licensure. The exploratory phase lasts between two and 24 years. It includes a comprehensive process during which governmental scientists and academic labs research natural and artificial ingredients that can stop or treat illnesses. In the second phase, a vaccine undergoes preclinical tests before administering it to human subjects. The tests use lab-grown cells and laboratory animals like monkeys to determine if it is safe or if it triggers a defense mechanism in the body. The results are defects or deficiencies, scientists can change a vaccine and refine the vaccine to administer it to animals to observe their response. If the vaccine produces undesirable results at that stage, it does not proceed to the next development phase. However, with the advancement of technology and increased scientific knowledge of how animal immune systems respond, scientists use computer models to predict laboratory results. The advancements reduce the cost of production and maintaining laboratory animals and ensure the vaccines do not pass the next phase if they do not produce desirable results. Finally, after successful clinical trials, companies seek regulation to test the vaccination on humans. Nevertheless, a company must explain the development process, provide summarized lab findings, and outline comprehensive research on human body. After companies defend their vaccines, the FDA ethics committee takes 30 days to review and approve human vaccination (History of Vaccines.org, n.d.). Vaccine development involves exploration, preclinical trials, and FDA approval before being tested on humans.

Vaccine administration in the United States follows four routes. The oral route involves the administration of vaccination drops through the mouth. The only vaccine that is routinely recommended to be administered orally is the Rotavirus vaccine and should never be administered through an injection. The second route is intranasal, administered through the nostril using a manufacturer-filled nasal sprayer. Live attenuated influenza (LAIV [FluMist]) is the only vaccine given using this route. The third route is subcutaneous, which entails injection into the fatty tissues below the dermis and above the muscle tissues. Finally, the intramuscular route is administered into the muscles via the skin and subcutaneous tissue. The administration site for this route depends on age, and the administrator must use a suitable needle length and gauge considering the recipient’s age, weight, and sex (Centers for Disease Control and Prevention, 2023). Thus, different vaccination routes allowed in the US follow distinct requirements to ensure maximum benefits to the recipient and avoid severe repercussions.

Sides Effects and Controversial Related to Vaccination

Even though vaccines are the most advanced medical invention in modern times, they have adverse effects. Common negative implications include swelling at the injection site, pain, fever, irritability, and rash (Spencer et al., 2017). The adverse effects cause vaccination controversy, with critics questioning its effectiveness in preventing and stopping illnesses without harming people. Besides, many people, including health workers and parents, are wary about vaccinating children because they are unsure if they can be fatal. Others claim that the development process and spurred regulations make vaccination questionable, increasing their hesitancy towards vaccines (Blume, 2017). One of the primary vaccine controversies was COVID-19, as many people questioned the effectiveness of the entire process. A study by Fieselmann et al. (2022) expounds that many people avoided vaccination against the virus because of low perceived benefits. Most people did not trust the efficacy of the newly developed COVID-19 vaccines, especially the mRNA-based or gene-based ones. For instance, they thought vaccines with mRNA were not sufficiently investigated or were ineffective. Thus, they did not consider such vaccines necessary or sensible in fighting the virus. Others were reluctant to get vaccinated because of health concerns, fearing the vaccines they would cause severe damage to their bodies. For instance, during the study, some users explained that the vaccines were experiments because they had not undergone long-term investigation to understand their possible side effects, including changes to people’s genetic makeup. These concerns relate to past vaccine and drug scandals, and since there was no sufficient data to support their efficacy, users feared they could cause more harm than good. Consequently, the adverse implications of vaccines force people to overlook their benefits, necessitating transparency during development and enlightening people to increase awareness.

Recommendations

Continuous vaccination controversies underscore the importance of transparency and accountability during preparation, development, and administration. As witnessed during the COVID-19 pandemic, lack of sufficient information and safety issues were the major concerns that reduced people’s willingness to get vaccinated. In the future, the healthcare sector should collaborate with relevant authorities to provide accessible and credible evidence-based information to inform people about vaccines, including their preparation and development. The information should seek to answer questions by vaccine-hesitant communities to address their concerns and increase their willingness to get vaccinated (Kerrigan et al., 2020). Thus, instead of strict governmental regulation, the public requires education on vaccinations to handle their concerns about safety and lack of information to increase their acceptance towards vaccines without feeling pressured.

Conclusion

Vaccine preparation and development follow stipulated principles and preclinical trials and exploration to guarantee their efficacy before being tested on humans. However, increased government regulation and side effects cause controversy, with many questioning their effectiveness in fighting pathogens without compromising lives.  After the spread of the COVID-19 pandemic, governments made it compulsory for people to get vaccinated to control the spread. However, many were unwilling to proceed with vaccination because there was no sufficient information to inform them on the vaccines’ efficacy. In addition, some people feared that the vaccines were hastily prepared, so they were unsure how vaccination would impact their bodies. In addition, most people feel pressured by their governments, even though they did not provide sufficient information to guarantee nothing would happen to adults and kids after vaccination. Therefore, the healthcare sector should collaborate with governments to ensure people receive enlightening and credible information on vaccines to make informed decisions. In addition, the healthcare sector should educate the public on vaccines to understand their pros and cons before getting vaccinated. Increasing society’s vaccination acceptance requires governments and health practitioners to collaborate in educating everyone on inoculation to ensure everything about vaccines is transparent and informative.